How Covid, 'industrial logic' and a threat played out in a multibillion-dollar biotech merger

Published on 1 Sep 2022 on American City Business Journals

Amgen Inc.'s persistence and patience won out in a 29-month saga that landed it a Peninsula company...

Read the rest of the article

Start tracking your investments with Statfolio

But just like anyone else, they could be wrong. If multiple institutions change their view on a...

Simply Wall St. · via Yahoo Finance 24 Dec 2024

The strategy involves buying the 10 highest-yielding stocks in the Dow Jones Industrial Average.,...

Barrons.com 24 Dec 2024

(Bloomberg) -- Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot cappe...

Bloomberg · via Yahoo Finance 23 Dec 2024

The pharmaceutical behemoth said its experimental weight-loss treatment helped patients lower the...

Invezz 20 Dec 2024

CT-388, a dual GLP-1/GIP receptor agonist, is being evaluated for the treatment of obesity in pat...

Zacks · via Yahoo Finance 19 Dec 2024

We recently compiled a list of the 10 Dogs of the Dow Dividend Stocks to Invest in. In this artic...

Insider Monkey · via Yahoo Finance 19 Dec 2024

Amgen's SWOT analysis: stock poised for growth amid obesity market potential

Investing.com 18 Dec 2024

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In...

Insider Monkey · via Yahoo Finance 17 Dec 2024

According to InvestingPro data, the company maintains a strong financial health score and has...

Investing.com 15 Dec 2024

Amgen Inc. (NASDAQ:AMGN) discovers, develops, manufactures and delivers human therapeutics...

Benzinga · via Yahoo Finance 14 Dec 2024